Advertisement

Release of Superoxide Anion and Enhanced Candidacidal Activity as a Manifestation of Macrophage Activation: Studies with Muramyl Dipeptide

  • Nancy P. Cummings
  • Michael J. Pabst
  • Richard B. JohnstonJr.
  • P. Elsbach
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 141)

Abstract

N-acetylmuramyl-L-alanyl-D-isoglutamine, or muramyl dipeptide (MDP), is a synthetic glycopeptide which has been formulated to correspond to a component found in a water-soluble extract of the cell wall of mycobacteria. It is the minimal structure that is capable of duplicating Freund’s complete adjuvant in the primary antibody response. 1,2 MDP added to in vitro systems stimulates a number of functions not necessarily related to the antibody response to specific antigens, such as release of pyrogens and lymphocyte activating factor from blood monocytes, enhanced collagenase and prostaglandin production from blood monocytes and mouse peritoneal cells, and inhibition of growth of mastocytoma cells.2,3

Keywords

Phorbol Myristate Acetate Phorbol Myristate Acetate Lysosomal Hydrolase Muramyl Dipeptide Control Macrophage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kotani, S., Watanabe, Y., Kinoshita, F., Shimono, T., Morisaki, I, Shiba, T., Kusumoto, S., Tarumi, Y., and Ikenaka, K., 1975, Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids, Biken J. 18: 105.PubMedGoogle Scholar
  2. 2.
    Chedid, L., Audibert, F., and Johnson, A. G., 1978, Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents, Prog. Allergy 25: 63.PubMedGoogle Scholar
  3. 3.
    Cummings, N. P., Pabst, M. J., and Johnston, R. B., Jr., Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide, J. Exp. Med., in press.Google Scholar
  4. 4.
    Johnston, R. B., Jr., Godzik, C. A., and Cohn, Z. A., 1978, Increased superoxide anion production by immunologically activated and chemically elicited macrophages, J. Exp. Med. 148: 115.PubMedCrossRefGoogle Scholar
  5. 5.
    Nathan, C. F., Brukner, L. H., Silverstein, S.C., and Cohn, Z. A., 1979, Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide, J. Exp. Med. 149: 84.PubMedCrossRefGoogle Scholar
  6. 6.
    Sasada, M. and Johnston, R. B., Jr., 1980, Macrophage microbicidal activity: correlation between phagocytosis-associated oxidative metabolism and the killing of candida by macrophages, J. Exp. Med. 152: 85.PubMedCrossRefGoogle Scholar
  7. 7.
    Pabst, M. J. and Johnston, R. B., Jr., 1980, Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide, J. Exp. Med. 151: 101.PubMedCrossRefGoogle Scholar
  8. 8.
    Schnyder, J. and Baggiolini, M., 1978, Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages, J. Exp. Med. 148: 435.PubMedCrossRefGoogle Scholar
  9. 9.
    Chedid, L., Parant, M., Parant, F., Audibert, F., Lefrancier, F., Choay, J., and Sela, M., 1979, Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly (DL-alanine)-poly ( L-lysine) carrier, Proc. Natl. Acad. Sci. U.S.A. 76: 6557.PubMedCrossRefGoogle Scholar
  10. 10.
    Kierszenbaum, F. and Ferraresi, R. W., 1979, Enhancement of host resistance against Trypanosoma cruzi infection by the iumiunoregulatory agent muramyl dipeptide, Infect. Immun. 25: 273.Google Scholar
  11. 11.
    McLaughlin, C. A. and Schwartzman, S. M., 1980, Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate, Science 208: 416.CrossRefGoogle Scholar
  12. 12.
    Dinarello, C. A., Elin, R. J., Chedid, L., and Wolff, S. M., The pyrogenicity of the synthetic adjuvant myramyl dipeptide and two structural analogues, J. Infect. Dis. 138: 760.Google Scholar
  13. 13.
    Kohashi, O., Kotani, S., Shiba, T., and Ozawa, A., 1979, Synergistic effect of polyriboinosinic acid: polyribocytidylic acid and either bacterial peptidoglycans or synthetic N-acetylmuramyl peptides on production of adjuvant-induced arthritis in rats, Infect. Immun. 26: 690.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Nancy P. Cummings
    • 1
  • Michael J. Pabst
    • 1
  • Richard B. JohnstonJr.
    • 1
  • P. Elsbach
  1. 1.National Jewish Hospital and Research Center and Departments of Pediatrics and BiochemistryUniversity of Colorado School of MedicineDenverUSA

Personalised recommendations